[1]
“Tissue distribution of crizotinib and gemcitabine combination in a patient-derived orthotopic mouse model of pancreatic cancer”, ADMET DMPK, vol. 4, no. 4, pp. 327–334, Dec. 2016, doi: 10.5599/admet.4.4.335.